Le Lézard
Classified in: Health, Covid-19 virus
Subjects: CFG, MAT

Advisory - Health Canada advises Canadians to help support the continued supply of medications


OTTAWA, June 1, 2020 /CNW/ -

Summary

Product: Various medications

Issue: The COVID-19 pandemic has resulted in significant shifts in the supply and demand of certain drugs. While supply levels may be stabilizing, supply pressures continue for certain drugs.

What to do: Do not buy more medication than usual to help ensure that all Canadians continue to have access to the medications they need and to help prevent drug shortages.

Issue
Health Canada recognizes that drug shortages can have a significant impact on patients and health care professionals and is committed to addressing them when they occur.

The COVID-19 pandemic has resulted in significant shifts in the supply and demand of certain drugs. While supply levels may be stabilizing, supply pressures continue for certain drugs.

Governments, industry, pharmacy organizations, and other health sector partners continue to work together to address supply issues, and are taking measures to conserve the supply of critical drugs.  Health Canada has been monitoring the supply situation closely and will take any necessary actions, in collaboration with its partners, to help ensure the continued supply of medications for Canadians.

Patients are advised not to buy more medication than required. This will help ensure that all Canadians continue to have access to the medications they need and to prevent drug shortages.

Canadians can access information on specific drug shortages at the Drug Shortages Canada website, where companies are required to report all actual and anticipated shortages within specific timeframes. Health Canada has also published a list of critical drugs that are in high demand or in shortage and is actively working in collaboration with industry and partners to mitigate impacts on patients.

For the latest and most up-to-date information on COVID-19, visit Canada.ca/coronavirus.

Également disponible en français

SOURCE Health Canada


These press releases may also interest you

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...



News published on and distributed by: